Detalhe da pesquisa
1.
Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity.
Mol Cancer
; 17(1): 171, 2018 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526604
2.
Pharmacodynamic modelling reveals synergistic interaction between docetaxel and SCO-101 in a docetaxel-resistant triple negative breast cancer cell line.
Eur J Pharm Sci
; 148: 105315, 2020 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201343